A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia
2011
The Journal of the Royal College of Physicians of Edinburgh
Preserved Fulltext
Arsenic trioxide has become the treatment of choice for patients with acute promyelocytic leukaemia. Cardiovascular toxicity is known to occur with this therapy, in particular heart rhythm disorders due to QT interval prolongation. We present a case of ventricular arrhythmia with no QT prolongation in a patient receiving arsenic trioxide therapy.
doi:10.4997/jrcpe.2011.204
pmid:21677914
fatcat:djfvcyur75bedkpkjwdyaynmoa